{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:57:10Z","timestamp":1791295030295,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transcriptional silencing via promoter methylation of genes important for cell growth and differentiation plays a key role in myeloid leukemogenesis. We find that clinically achievable levels of 5-aza-2\u2032-deoxycytidine (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor \u03b1 (TNF\u03b1) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937. Although 5-AZA-dC cannot fully induce differentiation, we show that 5-AZA-dC acts directly on TNF\u03b1-responsive promoters to facilitate TNF\u03b1-induced transcriptional pathways leading to differentiation. 5-AZA-dC regulates the expression of Dif-2, a TNF\u03b1 target gene, by deacetylating chromatin domains in a methylation-dependent manner. Chromatin immunoprecipitation analyses of the Dif-2 promoter show histone hyperacetylation and a recruitment of the nuclear factor-\u03baB transcription factor in response to 5-AZA-dC. Furthermore, 5-AZA-dC plus TNF\u03b1 enhances the level of phosphorylated RNA Pol II at the Dif-2 promoter via synergistic recruitment of TFIIH. We conclude that nonspecific changes in chromatin can allow a specific transcriptional inducer to overcome blocks in leukemic cell differentiation. Our results support the concept of low doses of 5-AZA-dC acting in combination with other agents to target epigenetic changes that drive malignant growth in leukemic cells. [Cancer Res 2009;69(1):55\u201364]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-0245","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T03:22:49Z","timestamp":1230693769000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of DNA Methyltransferase Activates Tumor Necrosis Factor \u03b1\u2013Induced Monocytic Differentiation in Acute Myeloid Leukemia Cells"],"prefix":"10.1158","volume":"69","author":[{"given":"Anna","family":"Laurenzana","sequence":"first","affiliation":[{"name":"1Segal Cancer Center and Lady Davis Institute of the Jewish General Hospital for Medical Research and"},{"name":"2Department of Oncology, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca A.","family":"Petruccelli","sequence":"additional","affiliation":[{"name":"1Segal Cancer Center and Lady Davis Institute of the Jewish General Hospital for Medical Research and"},{"name":"2Department of Oncology, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippa","family":"Pettersson","sequence":"additional","affiliation":[{"name":"1Segal Cancer Center and Lady Davis Institute of the Jewish General Hospital for Medical Research and"},{"name":"2Department of Oncology, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Figueroa","sequence":"additional","affiliation":[{"name":"3Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[{"name":"3Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert S.","family":"Baldwin","sequence":"additional","affiliation":[{"name":"4Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paoletti","sequence":"additional","affiliation":[{"name":"5Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Wilson H.","family":"Miller","sequence":"additional","affiliation":[{"name":"1Segal Cancer Center and Lady Davis Institute of the Jewish General Hospital for Medical Research and"},{"name":"2Department of Oncology, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,12,31]]},"reference":[{"key":"2022061700284516100_B1","doi-asserted-by":"crossref","unstructured":"Bird A. DNA methylation patterns and epigenetic memory. Genes Dev\u20082002; 16: 6\u201321.","DOI":"10.1101\/gad.947102"},{"key":"2022061700284516100_B2","doi-asserted-by":"crossref","unstructured":"Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell\u20081999; 99: 451\u20134.","DOI":"10.1016\/S0092-8674(00)81532-9"},{"key":"2022061700284516100_B3","doi-asserted-by":"crossref","unstructured":"Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res\u20081998; 72: 141\u201396.","DOI":"10.1016\/S0065-230X(08)60702-2"},{"key":"2022061700284516100_B4","doi-asserted-by":"crossref","unstructured":"Creusot F, Acs G, Christman JK. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2\u2032-deoxycytidine. J Biol Chem\u20081982; 257: 2041\u20138.","DOI":"10.1016\/S0021-9258(19)68144-5"},{"key":"2022061700284516100_B5","unstructured":"Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2\u2032-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res\u20081998; 58: 95\u2013101."},{"key":"2022061700284516100_B6","doi-asserted-by":"crossref","unstructured":"Momparler R, Bouchard J, Samson J. Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2\u2032-deoxycytidine. Leuk Res\u20081985; 9: 1361\u20136.","DOI":"10.1016\/0145-2126(85)90123-7"},{"key":"2022061700284516100_B7","doi-asserted-by":"crossref","unstructured":"Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor \u03b1 stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med\u20082000; 191: 275\u201386.","DOI":"10.1084\/jem.191.2.275"},{"key":"2022061700284516100_B8","doi-asserted-by":"crossref","unstructured":"Barkett M, Gilmore TD. Control of apoptosis by Rel\/NF-\u03baB transcription factors. Oncogene\u20081999; 18: 6910\u201324.","DOI":"10.1038\/sj.onc.1203238"},{"key":"2022061700284516100_B9","doi-asserted-by":"crossref","unstructured":"Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol\u20082001; 11: 372\u20137.","DOI":"10.1016\/S0962-8924(01)02064-5"},{"key":"2022061700284516100_B10","doi-asserted-by":"crossref","unstructured":"Karin M. Nuclear factor-\u03baB in cancer development and progression. Nature\u20082006; 441: 431\u20136.","DOI":"10.1038\/nature04870"},{"key":"2022061700284516100_B11","doi-asserted-by":"crossref","unstructured":"Chen F, Castranova V. Nuclear factor-\u03baB, an unappreciated tumor suppressor. Cancer Res\u20082007; 67: 11093\u20138.","DOI":"10.1158\/0008-5472.CAN-07-1576"},{"key":"2022061700284516100_B12","doi-asserted-by":"crossref","unstructured":"Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. p53 stabilization is decreased upon NF\u03baB activation: a role for NF\u03baB in acquisition of resistance to chemotherapy. Cancer Cell\u20082002; 1: 493\u2013503.","DOI":"10.1016\/S1535-6108(02)00068-5"},{"key":"2022061700284516100_B13","doi-asserted-by":"crossref","unstructured":"Kisseleva T, Song L, Vorontchikhina M, Feirt N, Kitajewski J, Schindler C. NF-\u03baB regulation of endothelial cell function during LPS-induced toxemia and cancer. J Clin Invest\u20082006; 116: 2955\u201363.","DOI":"10.1172\/JCI27392"},{"key":"2022061700284516100_B14","doi-asserted-by":"crossref","unstructured":"Witcher M, Shiu HY, Guo Q, Miller WH, Jr. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells. Blood\u20082004; 104: 3335\u201342.","DOI":"10.1182\/blood-2004-01-0023"},{"key":"2022061700284516100_B15","doi-asserted-by":"crossref","unstructured":"Laurenzana A, Pettersson F, Miller WJ. Role of PML\/RAR\u03b1 in the pathogenesis of APL. Drug Discovery Today Disease Mechanisms\u20082006; 3: 499\u2013505.","DOI":"10.1016\/j.ddmec.2006.11.008"},{"key":"2022061700284516100_B16","doi-asserted-by":"crossref","unstructured":"Licht JD. Reconstructing a disease: what essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia? Cancer Cell\u20082006; 9: 73\u20134.","DOI":"10.1016\/j.ccr.2006.01.024"},{"key":"2022061700284516100_B17","doi-asserted-by":"crossref","unstructured":"Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH, Jr. Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood\u20082003; 102: 237\u201345.","DOI":"10.1182\/blood-2002-09-2725"},{"key":"2022061700284516100_B18","doi-asserted-by":"crossref","unstructured":"Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A, Miller WH, Jr. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood\u20081996; 88: 2671\u201382.","DOI":"10.1182\/blood.V88.7.2671.bloodjournal8872671"},{"key":"2022061700284516100_B19","doi-asserted-by":"crossref","unstructured":"Witcher M, Pettersson F, Dupere-Richer D, et al. Retinoic acid modulates chromatin to potentiate tumor necrosis factor \u03b1 signaling on the DIF2 promoter. Nucl Acids Res\u20082008; 36: 435\u201343.","DOI":"10.1093\/nar\/gkm1058"},{"key":"2022061700284516100_B20","doi-asserted-by":"crossref","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem\u20081987; 162: 156\u20139.","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"2022061700284516100_B21","doi-asserted-by":"crossref","unstructured":"Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-\u03baB\/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol\u20082001; 166: 7128\u201335.","DOI":"10.4049\/jimmunol.166.12.7128"},{"key":"2022061700284516100_B22","unstructured":"Hass R, Bartels H, Topley N, et al. TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol\u20081989; 48: 282\u201393."},{"key":"2022061700284516100_B23","doi-asserted-by":"crossref","unstructured":"Ferreira OC, Jr., Valinsky JE, Sheridan K, Wayner EA, Bianco C, Garcia-Pardo A. Phorbol ester-induced differentiation of U937 cells enhances attachment to fibronectin and distinctly modulates the \u03b15\u03b21 and \u03b14\u03b21 fibronectin receptors. Exp Cell Res\u20081991; 193: 20\u20136.","DOI":"10.1016\/0014-4827(91)90533-Z"},{"key":"2022061700284516100_B24","doi-asserted-by":"crossref","unstructured":"Charrad RS, Gadhoum Z, Qi J, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood\u20082002; 99: 290\u20139.","DOI":"10.1182\/blood.V99.1.290"},{"key":"2022061700284516100_B25","doi-asserted-by":"crossref","unstructured":"Clark CS, Konyer JE, Meckling KA. 1\u03b1,25-Dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Exp Cell Res\u20082004; 294: 301\u201311.","DOI":"10.1016\/j.yexcr.2003.11.013"},{"key":"2022061700284516100_B26","doi-asserted-by":"crossref","unstructured":"Lu R, Pitha PM. Monocyte differentiation to macrophage requires interferon regulatory factor 7. J Biol Chem\u20082001; 276: 45491\u20136.","DOI":"10.1074\/jbc.C100421200"},{"key":"2022061700284516100_B27","doi-asserted-by":"crossref","unstructured":"Sykes DB, Scheele J, Pasillas M, Kamps MP. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein. Leuk Lymphoma\u20082003; 44: 1187\u201399.","DOI":"10.1080\/1042819031000090273"},{"key":"2022061700284516100_B28","doi-asserted-by":"crossref","unstructured":"Sherman ML, Stone RM, Datta R, Bernstein SH, Kufe DW. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem\u20081990; 265: 3320\u20133.","DOI":"10.1016\/S0021-9258(19)39769-8"},{"key":"2022061700284516100_B29","doi-asserted-by":"crossref","unstructured":"Pietzsch A, Buchler C, Schmitz G. Genomic organization, promoter cloning, and chromosomal localization of the Dif-2 gene. Biochem Biophys Res Commun\u20081998; 245: 651\u20137.","DOI":"10.1006\/bbrc.1998.8500"},{"key":"2022061700284516100_B30","doi-asserted-by":"crossref","unstructured":"Ziegelbauer K, Gantner F, Lukacs NW, et al. A selective novel low-molecular-weight inhibitor of I\u03baB kinase-\u03b2 (IKK-\u03b2) prevents pulmonary inflammation and shows broad anti-inflammatory activity. Br J Pharmacol\u20082005; 145: 178\u201392.","DOI":"10.1038\/sj.bjp.0706176"},{"key":"2022061700284516100_B31","doi-asserted-by":"crossref","unstructured":"Santi DV, Norment A, Garrett CE. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. Proc Natl Acad Sci U S A\u20081984; 81: 6993\u20137.","DOI":"10.1073\/pnas.81.22.6993"},{"key":"2022061700284516100_B32","doi-asserted-by":"crossref","unstructured":"Bestor TH. Gene silencing. Methylation meets acetylation. Nature\u20081998; 393: 311\u20132.","DOI":"10.1038\/30613"},{"key":"2022061700284516100_B33","doi-asserted-by":"crossref","unstructured":"Nissen RM, Yamamoto KR. The glucocorticoid receptor inhibits NF\u03baB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev\u20082000; 14: 2314\u201329.","DOI":"10.1101\/gad.827900"},{"key":"2022061700284516100_B34","doi-asserted-by":"crossref","unstructured":"Hirose Y, Ohkuma Y. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J Biochem Tokyo\u20082007; 141: 601\u20138.","DOI":"10.1093\/jb\/mvm090"},{"key":"2022061700284516100_B35","doi-asserted-by":"crossref","unstructured":"Daniel D, Wilson NS. Tumor necrosis factor: renaissance as a cancer therapeutic? Current cancer drug targets\u20082008; 8: 124\u201331.","DOI":"10.2174\/156800908783769346"},{"key":"2022061700284516100_B36","doi-asserted-by":"crossref","unstructured":"Kuwano K, Hara N. Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am J Respir Cell Mol Biol\u20082000; 22: 147\u20139.","DOI":"10.1165\/ajrcmb.22.2.f178"},{"key":"2022061700284516100_B37","doi-asserted-by":"crossref","unstructured":"Pietzsch A, Buchler C, Aslanidis C, Schmitz G. Identification and characterization of a novel monocyte\/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide, and lysophosphatidylcholine. Biochem Biophys Res Commun\u20081997; 235: 4\u20139.","DOI":"10.1006\/bbrc.1997.6715"},{"key":"2022061700284516100_B38","doi-asserted-by":"crossref","unstructured":"Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-\u03baB-mediated cell survival. Science\u20081998; 281: 998\u20131001.","DOI":"10.1126\/science.281.5379.998"},{"key":"2022061700284516100_B39","doi-asserted-by":"crossref","unstructured":"Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature\u20081998; 393: 386\u20139.","DOI":"10.1038\/30764"},{"key":"2022061700284516100_B40","doi-asserted-by":"crossref","unstructured":"Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet\u20081998; 19: 187\u201391.","DOI":"10.1038\/561"},{"key":"2022061700284516100_B41","doi-asserted-by":"crossref","unstructured":"Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet\u20082003; 33: 61\u20135.","DOI":"10.1038\/ng1068"},{"key":"2022061700284516100_B42","doi-asserted-by":"crossref","unstructured":"Santi DV, Garrett CE, Barr PJ. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell\u20081983; 33: 9\u201310.","DOI":"10.1016\/0092-8674(83)90327-6"},{"key":"2022061700284516100_B43","doi-asserted-by":"crossref","unstructured":"Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res\u20082007; 67: 1424\u20139.","DOI":"10.1158\/0008-5472.CAN-06-4218"},{"key":"2022061700284516100_B44","doi-asserted-by":"crossref","unstructured":"Koturbash I, Boyko A, Rodriguez-Juarez R, et al. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis\u20082007; 28: 1831\u20138.","DOI":"10.1093\/carcin\/bgm053"},{"key":"2022061700284516100_B45","doi-asserted-by":"crossref","unstructured":"Momparler RL, Rivard GE, Gyger M. Clinical trial on 5-aza-2\u2032-deoxycytidine in patients with acute leukemia. Pharmacol Ther\u20081985; 30: 277\u201386.","DOI":"10.1016\/0163-7258(85)90052-X"},{"key":"2022061700284516100_B46","doi-asserted-by":"crossref","unstructured":"Schrump DS, Fischette MR, Nguyen DM, et al. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Clin Cancer Res\u20082006; 12: 5777\u201385.","DOI":"10.1158\/1078-0432.CCR-06-0669"},{"key":"2022061700284516100_B47","doi-asserted-by":"crossref","unstructured":"Weiser TS, Guo ZS, Ohnmacht GA, et al. Sequential 5-aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J Immunother\u20082001; 24: 151\u201361.","DOI":"10.1097\/00002371-200103000-00010"},{"key":"2022061700284516100_B48","doi-asserted-by":"crossref","unstructured":"Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S, Gutterman JU. A phase I trial of intravenously-administered recombinant tumor necrosis factor-\u03b1 in cancer patients. J Clin Oncol\u20081988; 6: 1328\u201334.","DOI":"10.1200\/JCO.1988.6.8.1328"},{"key":"2022061700284516100_B49","doi-asserted-by":"crossref","unstructured":"Witcher M, Pettersson F, Dupere-Richer D, et al. Retinoic acid modulates chromatin to potentiate tumor necrosis factor \u03b1 signaling on the DIF2 promoter. Nucleic Acids Res\u20082008; 36: 435\u201343.","DOI":"10.1093\/nar\/gkm1058"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/1\/55\/2609884\/55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/1\/55\/2609884\/55.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:14:06Z","timestamp":1655428446000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/1\/55\/549549\/Inhibition-of-DNA-Methyltransferase-Activates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,12,31]]},"published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-0245","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6498092.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376087.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376090","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376090.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376087","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498092","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,31]]}}}